within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01X_OtherAntibacterials.J01XX09_Daptomycin;

model Daptomycin
  extends Pharmacolibrary.Drugs.ATC.J.J01XX09;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01XX09</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of infections caused by Gram-positive bacteria, including complicated skin and skin structure infections and Staphylococcus aureus bacteremia, including right-sided infective endocarditis. It is approved by the FDA and continues to be in clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adult volunteers after a single intravenous 4 mg/kg dose.</p><h4>References</h4><ol><li><p>Wu, J, et al., &amp; Wu, D (2024). Population pharmacokinetics of intravenous daptomycin in critically ill patients: implications for selection of dosage regimens. <i>Frontiers in pharmacology</i> 15 1378872–None. DOI:<a href=\"https://doi.org/10.3389/fphar.2024.1378872\">10.3389/fphar.2024.1378872</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38756382/\">https://pubmed.ncbi.nlm.nih.gov/38756382</a></p></li><li><p>Ishii, M, et al., &amp; Yoshitsugu, H (2023). Pharmacokinetics of intravenous daptomycin in Japanese pediatric patients: Pharmacokinetic comparisons supporting dosing recommendations in Japanese pediatric patients. <i>Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy</i> 29(6) 592–598. DOI:<a href=\"https://doi.org/10.1016/j.jiac.2023.02.012\">10.1016/j.jiac.2023.02.012</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36868408/\">https://pubmed.ncbi.nlm.nih.gov/36868408</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=\"https://doi.org/10.1007/s40272-013-0017-5\">10.1007/s40272-013-0017-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23529866/\">https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Daptomycin;
